Enhanced Personalized Atrial Fibrillation Ablation System

Publication ID: 24-11857263_0006_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Personalized Atrial Fibrillation Ablation System,” Published Technical Disclosure No. 24-11857263_0006_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857263_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,263.

Summary of the Inventive Concept

An improved system for personalized atrial fibrillation ablation, providing more precise and effective treatment through advanced 3D modeling, real-time feedback, and adaptive ablation patterns.

Background and Problem Solved

The original patent disclosed a personalized atrial fibrillation ablation device utilizing a 3D model of the patient's heart. However, the device had limitations in accommodating variations in pulmonary vein anatomy and lacked real-time feedback to adjust the ablation process. The new inventive concept addresses these limitations by introducing an adjustable ablation panel and a real-time feedback system.

Detailed Description of the Inventive Concept

The enhanced system comprises a three-dimensional model generator, an ablation catheter custom-designed based on the model, and a real-time feedback system to monitor and adjust the ablation process. The ablation panel is adjustable to accommodate variations in pulmonary vein anatomy, ensuring a more precise and effective treatment. The real-time feedback system includes a sensor array to detect changes in the patient's heart rhythm during ablation and a control unit to adjust the ablation pattern in response to the detected changes.

Novelty and Inventive Step

The new claims introduce the concept of an adjustable ablation panel and a real-time feedback system, which are not present in the original patent. These features provide a more adaptive and effective treatment, making the new inventive concept novel and non-obvious.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of sensors or imaging modalities to generate the 3D model, or incorporating machine learning algorithms to optimize the ablation pattern. Variations could also include using the system for treating other cardiac arrhythmias or integrating it with other medical devices.

Potential Commercial Applications and Market

The enhanced personalized atrial fibrillation ablation system has significant commercial potential in the medical device industry, particularly in the cardiac electrophysiology market. It could be marketed as a premium product for hospitals and clinics, offering improved treatment outcomes and reduced procedure times.

CPC Classifications

SectionClassGroup
A A61 A61B34/10
A A61 A61B18/1492
A A61 A61B2017/00526
A A61 A61B2018/00375
A A61 A61B2018/00577
A A61 A61B2034/104
A A61 A61B2034/105
A A61 A61B2090/374
A A61 A61B2090/378
A A61 A61B2090/3762
A A61 A61M25/0009

Field of Art

Medical Device Technology, specifically Cardiac Intervention and Electrophysiological Treatment Systems, involving advanced imaging, ablation techniques, and personalized medical interventions

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional cardiologist with expertise in cardiac mapping, 3D medical imaging, ablation technologies, and electrophysiological intervention techniques, possessing advanced technical knowledge of medical device design and cardiac treatment methodologies

Obviousness Rationale

A PHOSITA would recognize that the PTD's disclosed variations represent predictable extensions of the source patent's core personalized ablation technology, utilizing standard engineering design approaches to enhance precision, adaptability, and treatment effectiveness through incremental technical improvements that would be apparent to a skilled practitioner in cardiac intervention technologies.

Obvious Combinations & Variations

Source Patent Element
Three-dimensional model of patient's heart used for customizing ablation catheter
PTD Variation
Adding real-time feedback system and sensor array to dynamically adjust ablation pattern
Obviousness Reasoning
Integrating adaptive sensing technologies is a known technique in medical device design, representing a predictable enhancement to improve treatment precision and patient safety
Source Patent Element
Ablation panel configured to create specific ablation pattern in left atrium
PTD Variation
Introducing an adjustable ablation panel to accommodate variations in pulmonary vein anatomy
Obviousness Reasoning
Designing flexible medical devices to address anatomical variations is a standard engineering approach with finite, predictable solution sets
Source Patent Element
Ostial fitment elements for engaging pulmonary veins
PTD Variation
Incorporating machine learning algorithms to optimize ablation pattern based on individual patient data
Obviousness Reasoning
Applying computational optimization techniques to medical device design represents an obvious evolution of existing personalization strategies
Source Patent Element
Base ring with mesh material covering opening
PTD Variation
Expanding imaging modalities for generating three-dimensional heart model
Obviousness Reasoning
Exploring alternative imaging technologies is a routine design approach for improving medical diagnostic and intervention capabilities
Source Patent Element
Trigger and sensing electrodes for monitoring ablation pattern
PTD Variation
Developing comprehensive sensor array for detecting multiple cardiac signal characteristics
Obviousness Reasoning
Expanding sensor capabilities represents a predictable technological progression in medical monitoring technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857263 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and lacking inventive merit, as the proposed enhancements represent straightforward extensions of existing personalized atrial fibrillation ablation technologies through standard engineering design methodologies and predictable technological improvements.

Original Patent Information

Patent NumberUS 11,857,263
TitlePersonalized atrial fibrillation ablation